Sulfamethoxypyridazine D3

Sulfamethoxypyridazine D3 is a deuterated form of the antibacterial drug Sulfamethoxypyridazine. It is a member of the Sulfonamide class of antibiotics which work by inhibiting the growth of bacteria by interfering with the synthesis of folic acid. Sulfamethoxypyridazine D3 is used to treat bacterial infections such as urinary tract infections, respiratory tract infections, and skin infections. It can also be used in combination with other antibiotics to treat more serious infections. It is effective against a wide range of bacteria including Escherichia coli, Streptococcus pneumoniae and Staphylococcus aureus. The chemical structure of Sulfamethoxypyridazine D3 consists of a pyridazine ring attached to a sulfonamide group and a methyl group. The deuterium atoms are incorporated into the methyl group of the molecule. The deuterated form of the drug is used in pharmacokinetic studies to determine the metabolism and elimination of the drug in the body. Sulfamethoxypyridazine D3 is typically administered orally in tablet form and is rapidly absorbed into the bloodstream. It is primarily eliminated through the kidneys and has a half-life of approximately 8 hours in healthy individuals. Adverse effects of the drug include gastrointestinal disturbances, skin rashes, and allergic reactions. In rare cases, it can cause more serious side effects such as blood disorders and liver damage.